The Role of Capecitabine/Temozolomide in Metastatic Neuroendocrine Tumors. - Wikidata - wikimedia - TriplyDB

The Role of Capecitabine/Temozolomide in Metastatic Neuroendocrine Tumors.

The Role of Capecitabine/Temozolomide in Metastatic Neuroendocrine Tumors.

http://www.wikidata.org/entity/Q37017037

about

New therapeutic approaches to metastatic gastroenteropancreatic neuroendocrine tumors: A glimpse into the future.The PARP inhibitor ABT-888 potentiates dacarbazine-induced cell death in carcinoids.The Surgical Management of Small Bowel Neuroendocrine Tumors: Consensus Guidelines of the North American Neuroendocrine Tumor Society.Combination therapy with capecitabine and temozolomide in patients with low and high grade neuroendocrine tumors, with an exploratory analysis of O6-methylguanine DNA methyltransferase as a biomarker for response.Management of pulmonary neuroendocrine tumors.Role of Fluorouracil, Doxorubicin, and Streptozocin Therapy in the Preoperative Treatment of Localized Pancreatic Neuroendocrine Tumors.Capecitabine and Temozolomide in Neuroendocrine Tumor of Unknown Primary.

P2860

Q30364864-4481015C-E801-463A-BDDD-3853E321A0FD Q37372483-F8A0BE71-99FD-40F8-BB7C-564685B58D29 Q38727852-A4838FD5-593A-4720-A276-499D2A7D99F3 Q47270129-48E9F2FE-4A35-4213-A74D-15BE0AD2D31C Q50227317-06FEC932-8B58-4AD0-A130-5E45496E8FB7 Q53027231-6D199B23-D515-40FA-B4EE-4DF73A45BCC4 Q55395981-22B53CD9-0FB8-4816-B710-0ECD1941C2D0

P2860

The Role of Capecitabine/Temozolomide in Metastatic Neuroendocrine Tumors.

http://www.wikidata.org/entity/Q37017037

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 25 May 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

The Role of Capecitabine/Temozolomide in Metastatic Neuroendocrine Tumors.

@en

The Role of Capecitabine/Temozolomide in Metastatic Neuroendocrine Tumors.

@nl

type

label

The Role of Capecitabine/Temozolomide in Metastatic Neuroendocrine Tumors.

@en

The Role of Capecitabine/Temozolomide in Metastatic Neuroendocrine Tumors.

@nl

prefLabel

The Role of Capecitabine/Temozolomide in Metastatic Neuroendocrine Tumors.

@en

The Role of Capecitabine/Temozolomide in Metastatic Neuroendocrine Tumors.

@nl

P1433

Q37017037-255267F6-099C-487B-BA35-FA827475E670

P1476

Q37017037-FC837522-9CEF-4DB3-9357-34833090AC85

P2093

Q37017037-18B31E16-60FE-488A-B357-1768FEF45289

Q37017037-4AE82B7C-57B3-41BE-8251-CDF43BACDAEA

Q37017037-5686C79E-44E2-43D7-9B67-E8DECBF02A2F

Q37017037-70B01673-37A1-4595-8928-D27778FB159C

Q37017037-86A37889-91B2-4A02-A517-B3F8869F1544

Q37017037-E3266E56-6A4D-452F-B835-F685AFEF51A5

P2860

Q37017037-112C832C-0E8F-423A-952D-37A8B6CFD9B0

Q37017037-296AFF9A-69A2-4401-BF37-E551FB13FB7A

Q37017037-3F16CC5E-F13E-49CC-8964-BE0EA103D5B8

Q37017037-426E074F-FEBC-4409-AE20-5AB82A89F5E3

Q37017037-4F7CDEA7-97E6-41ED-8DA5-A6FE64D18162

Q37017037-5C3EBB33-11C1-4FDC-93EC-0E94C3222652

Q37017037-7134A907-37C7-4846-A4BF-287AD3FAB8CC

Q37017037-79F4072C-D3FA-4C1B-BFF0-DE212DA322B4

Q37017037-913EA658-B63F-41AA-A88A-C0067F2B6EA3

Q37017037-9E96C76B-8A21-4930-A37F-B52C52DD0996

P304

Q37017037-20C27546-12C4-4146-BB25-59E9A12A981E

P31

Q37017037-5D72A52A-03E7-4AB3-BB32-8442D8C90779

P356

Q37017037-021F787A-6758-4A73-940B-6D71B876D8ED

P433

Q37017037-A8F9441A-B883-4AC1-8A36-A1065D70F57C

P478

Q37017037-8C38D879-137C-46AF-90ED-19BB469B4295

P577

Q37017037-3D7D2C82-AC0D-4422-ABF1-F7D5BA20DB0B

P698

Q37017037-89122E38-3F9A-476D-829E-D591AD491710

P932

Q37017037-EAE55D4A-26AC-4D1E-A47B-AAA839593FF6

P356

THEONCOLOGIST.2015-0470

P1433

P1476

The Role of Capecitabine/Temozolomide in Metastatic Neuroendocrine Tumors.

@en

P2093

Aman Chauhan

http://www.w3.org/2001/XMLSchema#string

David T Beyer

http://www.w3.org/2001/XMLSchema#string

Eugene A Woltering

http://www.w3.org/2001/XMLSchema#string

J Philip Boudreaux

http://www.w3.org/2001/XMLSchema#string

Robert A Ramirez

http://www.w3.org/2001/XMLSchema#string

Yi-Zarn Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Gastroenteropancreatic neuroendocrine tumours

Temozolomide as monotherapy is effective in treatment of advanced malignant neuroendocrine tumors.

Prospective study of bevacizumab plus temozolomide in patients with advanced neuroendocrine tumors.

Capecitabine and temozolomide (CAPTEM) for metastatic, well-differentiated neuroendocrine cancers: The Pancreas Center at Columbia University experience.

Chemotherapy with 5-fluorouracil, cisplatin and streptozocin for neuroendocrine tumours.

Outcomes of patients treated with capecitabine and temozolamide for advanced pancreatic neuroendocrine tumors (PNETs) and non-PNETs

The diagnosis and medical management of advanced neuroendocrine tumors.

Chemoembolization and other ablative therapies for liver metastases of gastrointestinal endocrine tumours.

First-line chemotherapy with capecitabine and temozolomide in patients with metastatic pancreatic endocrine carcinomas.

One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States.

P304

671-675

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1634/THEONCOLOGIST.2015-0470

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

21

http://www.w3.org/2001/XMLSchema#string

P577

2016-05-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27226359

http://www.w3.org/2001/XMLSchema#string

P932

4912368

http://www.w3.org/2001/XMLSchema#string